1. Signaling Pathways
  2. Cell Cycle/DNA Damage
  3. HMG Family

HMG Family (高迁移率族蛋白家族)

High Mobility Group Family

高迁移率族 (HMG) 蛋白是一个丰富且普遍存在的核蛋白超家族,可与 DNA 和核小体结合并诱导染色质纤维的结构变化。HMG 家族蛋白包括 HMGB、HMGN 和 HMGA 亚家族,它们是高度进化保守的核蛋白。这三个 HMG 家族调节发育过程和肿瘤发生。HMGB1 (也称为 HMG1、HMG-1 和两性蛋白) 是所有 HMG 家族成员中最丰富的蛋白质,也是细胞核中第二丰富的蛋白质,在哺乳动物细胞和组织中广泛表达。HMGB1 是一种报警信号蛋白,可促进炎症促进免疫细胞的募集和激活。HMG 蛋白受发育调控,HMG 蛋白水平的变化会改变细胞表型,并可能导致发育异常和疾病[1][2]

The high mobility group (HMG) proteins are a superfamily of abundant and ubiquitous nuclear proteins that bind to DNA and nucleosomes and induce structural changes in the chromatin fiber. HMG family proteins include HMGB, HMGN, and HMGA subfamilies, which are highly evolutionarily conserved nuclear proteins. The three HMG families in modulating developmental processes and tumorigenesis. As the most abundant protein among all the HMG family members and the second-most abundant protein in the nucleus, HMGB1 (also known as HMG1, HMG-1, and amphoterin) is widely expressed in mammalian cells and tissues. HMGB1 is a type of alarm signal protein that promotes the recruitment and activation of inflammation-promoting immune cells. HMG proteins is developmentally regulated and that changes in HMG protein levels alter the cellular phenotype and can lead to de

HMG Family 相关产品 (3):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-P9928
    Alirocumab

    阿利西尤单抗

    Alirocumab 是一种抗 PCSK9 人单克隆抗体。Alirocumab 可抑制 PCSK9。Alirocumab 可减少 NLRP3 inflammasome,调节 Nrf2/HO-1HMGB1/NF-κBFractalkine/CX3CR1。Alirocumab 可增强肝脏结合 LDL 胆固醇 (LDL-C) 的能力,并降低血液中的 LDL-C 水平。Alirocumab 可改善动脉粥样硬化和炎症。
    Alirocumab
  • HY-P9928A
    Alirocumab (anti-PCSK9)

    阿利西尤单抗 (anti-PCSK9)

    98.24%
    Alirocumab (anti-PCSK9) 是一种抗 PCSK9 人单克隆抗体。Alirocumab (anti-PCSK9) 可抑制 PCSK9。Alirocumab (anti-PCSK9) 可减少 NLRP3 inflammasome,调节 Nrf2/HO-1HMGB1/NF-κBFractalkine/CX3CR1。Alirocumab (anti-PCSK9) 可增强肝脏结合 LDL 胆固醇 (LDL-C) 的能力,并降低血液中的 LDL-C 水平。Alirocumab (anti-PCSK9) 可改善动脉粥样硬化和炎症。
    Alirocumab (anti-PCSK9)
  • HY-116940
    Sm4 Inhibitor 99.37%
    Sm4 是一种 SOX18 抑制剂。Sm4 显示 SOX18-DNA 结合抑制活性。Sm4 选择性影响体外 SOX18 转录输出。Sm4 阻断体内 SoxF 转录活性。Sm4可用于肿瘤转移和血管癌的研究。
    Sm4